IS IT FEASIBLE TO WITHDRAW IMMUNOSUPPRESSIVE TREATMENT IN REAL-LIFE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS?

被引：0
|
作者：
Monti, S. [1 ,2 ]
Vitolo, B. [1 ]
Balduzzi, S. [1 ]
Felicetti, M. [3 ]
Padoan, R. [3 ]
Berti, A. [4 ]
Bond, M. [5 ]
Quartuccio, L. [5 ]
Paolazzi, G. [4 ]
Schiavon, F. [3 ]
Montecucco, C. [1 ]
Caporali, R. [1 ]
机构：
[1] IRCCS Policlin S Matteo Fdn, Rheumatol, Pavia, Italy
[2] Univ Pavia, PhD Expt Med, Pavia, Italy
[3] Univ Padua, Rheumatol, Padua, Italy
[4] Santa Chiara Hosp, Rheumatol, Trento, Italy
[5] Univ Hosp S Maria della Misericordia, Rheumatol, Udine, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.4838
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0700
引用
收藏
页码：1491 / 1491
页数：1
相关论文
共 50 条
  • [1] OUTCOME AND IMMUNOSUPPRESSIVE TREATMENT OF ELDERLY PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Kato, Akiko
    Ito, Eri
    Kamegai, Naoki
    Mizutani, Minami
    Shimogushi, Hiroya
    Tanaka, Akihito
    Shinjo, Hibiki
    Otsuka, Yasuhiro
    Inaguma, Daijo
    Takeda, Asami
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 382 - 383
  • [2] Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort
    Fabián Carranza-Enríquez
    José Antonio Meade-Aguilar
    Andrea Hinojosa-Azaola
    Clinical Rheumatology, 2022, 41 : 2809 - 2816
  • [3] Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort
    Carranza-Enriquez, Fabian
    Antonio Meade-Aguilar, Jose
    Hinojosa-Azaola, Andrea
    CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2809 - 2816
  • [4] AVACOPAN IN THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS: MULTICENTER PROSPECTIVE REAL-LIFE STUDY ON EFFICACY, SAFETY, AND IMPACT ON QUALITY OF LIFE
    Treppo, E.
    De Martino, M.
    Bello, F.
    Padoan, R.
    Monti, S.
    Moroni, L.
    Affatato, S.
    Conticini, E.
    Galli, E.
    Marvisi, C.
    Tombetti, E.
    Frediani, B.
    Alberici, F.
    Dagna, L.
    Delvino, P.
    Schiavon, F.
    Emmi, G.
    Salvarani, C.
    Isola, M.
    Quartuccio, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [5] Obinutuzumab in the Treatment of Patients with ANCA-associated Vasculitis
    Herzog, Carolin
    Gross, Christian Rudolf
    Mertens, Peter Rene
    Tanev, Ivan
    Braun-Dullaeus, Ruediger Christian
    Suess, Kathleen
    INNERE MEDIZIN, 2024, 65 : S157 - S157
  • [6] Treatment of ANCA-associated vasculitis
    Langford, CA
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01): : 3 - 4
  • [7] Treatment of ANCA-associated vasculitis
    Wise, Matt P.
    Frost, Paul
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (23): : 2739 - 2740
  • [8] Treatment of ANCA-associated vasculitis
    Schoenermarck, Ulf
    Gross, Wolfgang L.
    de Groot, Kirsten
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (01) : 25 - 36
  • [9] Treatment of ANCA-associated vasculitis
    Ulf Schönermarck
    Wolfgang L. Gross
    Kirsten de Groot
    Nature Reviews Nephrology, 2014, 10 : 25 - 36
  • [10] Limitations of Standard Immunosuppressive Treatment in ANCA-Associated Vasculitis and Lupus Nephritis
    Tesar, Vladimir
    Hruskova, Zdenka
    NEPHRON CLINICAL PRACTICE, 2014, 128 (3-4): : 205 - 215
12345